IP Library › Granted Patent US 8,207,211
Granted Patent B2
US 8,207,211 · App. 11/885,241 · Granted Jun 26, 2012

Photosensitizers for targeted photodynamic therapy

Assignees: The General Hospital Corporation; Lynntech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,207,211
App. No.
11/885,241
Granted
Jun 26, 2012
Kind
B2
Abstract

The present invention relates to photosensitizer compounds based on functionalized fullerenes useful in targeted photodynamic therapy (PDT), and methods of use thereof.

Claims (5)

1. A functionalized fullerene compound of the formula:

2. A pharmaceutical composition, comprising:

a biocompatible carrier and an effective amount of a functionalized fullerene compound of claim 1 .

3. The pharmaceutical composition of claim 2 , wherein the composition is a solution having a fullerene concentration of between 1 and 100 micromolar.

4. The composition of claim 2 , further comprising a hyperosmotically active chemical species.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2008
From: WHARTON, TIM; GALI, HARIPRASAD
To: LYNNTECH, INC.
Reel/Frame 021277/0194 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2008
From: HAMBLIN, MICHAEL R.
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 021277/0199 →
Continuity (2)
Provisional Application 60657181 · Feb 28, 2005
Related Publication 20090076115A1 · Mar 19, 2009